Pixium Vision said today that its Prima miniature wireless photovoltaic sub-retinal implant has been activated in the first five patients. The patients all have severe vision loss from atrophic dry age-related macular degeneration. They are enrolled in a three-year clinical study in France to evaluate the safety and function of the Prima chip in eliciting visual […]
Pixium Vision touts 1st use of Prima bionic vision system
Pixium Vision (EPA:PIX) yesterday announced the first successful trial implantation and activation of its Prima next-generation miniaturized wireless photovoltaic sub-retinal implant, and that the system successfully produced visual perception. With the implantation complete, the patient will begin the re-education phase of the study which includes a six-month and 36-month follow-up, the Paris-based company said. “This first […]
Pixium Vision wins FDA nod for Prima sub-retinal implant study
Pixium Vision (EPA:PIX) said today it won FDA approval to launch a clinical feasibility trial of its Prima next-gen miniaturized wireless photovoltaic sub-retinal implant designed to treat patients with atrophic dry age-related macular degeneration. The trial of the device, which is slated to be conducted at the University of Pittsburgh Medical Center, aims ot recruit 5 patients […]
Pixium Vision wins French approval for Prima sub-retinal implant study
Pixium Vision (EPA:PIX) said today it won approval from France’s regulatory agency to launch a feasibility clinical study of its next-gen Prima sub-retinal implant in patients with advanced dry age-related macular degeneration. The Prima system is a next-gen wireless implant with a micro photovoltaic chip designed to be implanted under the retina to convert pulsed near-infra-red invisible […]
7 medtech stories we missed: Feb. 17, 2017
Several companies released diabetes study results this week, while companies like BioTime closed on their public offerings and Pixium implanted its first bionic eye. Here are 7 medtech stories we missed this week, but were still worth mentioning. 1. Insulet touts glucose control study Insulet Corp. announced the results from its first feasibility study of its Omnipod […]
Pixium logs German reimbursement win for Iris II ‘bionic eye’
Pixium Vision (EPA:PIX) said today that its Iris II ‘bionic eye’ won NUB 1 reimbursement status from the German Institute for the Hospital Remuneration System. The company’s epi-retinal implant has 150 electrodes and a bio-inspired camera intended for patients who have lost sight due to retinitis pigmentosa. A computer processes images captured by the camera and […]
First patient receives Pixium bionic vision implant
Pixium Vision (EPA:PIX) said today that the 1st patient in the UK was implanted with its IRIS II bionic vision system. The epi-retinal implant has 150 electrodes and a bio-inspired camera intended for patients who have lost sight due to retinitis pigmentosa. The French company said the implantation and activation was performed in September by principal […]
Pixium Vision wins CE Mark for Iris II retinal prosthesis
French retinal implant maker Pixium Vision said Monday it won CE Mark approval in the European Union for its Iris II bionic vision system designed for individuals with vision loss from outer retinal degeneration. The Iris system is comprised of a retinal implant and a pair of camera-mounted glasses connected to a “pocket computer.” The computer processes […]
Pixium wins UK nod for Iris II ‘bionic eye’ trial
French retinal implant maker Pixium Vision said today it won U.K. Medicines & Healthcare products Regulatory Agency approval to initiate a clinical trial of its Iris II bionic vision system designed to restore sight to patients with retinitis pigmentosa. The Iris system is comprised of a retinal implant and a pair of camera-mounted glasses connected to a […]
Pixium Vision touts 1st-in-human for Iris II retinal implant
French retinal implant maker Pixium Vision today announced the 1st implantation and successful activation of its Iris II epi-retinal implant designed for patients with vision loss as a result of retinitis pigmentosa. The Iris system is comprised of a retinal implant and a pair of camera-mounted glasses connected to a “pocket computer.” The computer processes […]
Baxter adds 30 jobs in Malta | Medtech personnel moves for the week of Apr. 7, 2014
Report: Baxter to add 30 jobs in Malta
April 2, 2014 by Arezu Sarvestani
Malta regulators announced this week that healthcare titan Baxter plans to add 30 additional jobs in the country.
